ZCA
BLUE

Zeke Capital Advisors’s bluebird bio BLUE Stock Holding History

Zeke Capital Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-237
Closed -$481K – 653
2018
Q2 		$481K Hold
237
– – 0.04% 308
2018
Q1 		$524K Buy
237
+37
+19% +$94.1K 0.05% 318
2017
Q4 		$461K Buy
+200
New +$406K 0.05% 307

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zeke Capital Advisors's BLUE Position: Q3 2018 in Review

Zeke Capital Advisors sold out of bluebird bio (BLUE) in Q3 2018, closing a stake of 237 shares — an estimated $481K sold.

Zeke Capital Advisors first reported a position in BLUE in Q4 2017 and held it in 3 quarters. The position peaked at $524K in Q1 2018. 288 funds tracked by Wall St. Rank hold BLUE as of Q3 2018.

  • Zeke Capital Advisors reported no remaining bluebird bio position as of Q3 2018 after selling out during the quarter.
  • Zeke Capital Advisors sold 237 bluebird bio shares in Q3 2018, an estimated $481K.
  • Zeke Capital Advisors first reported a position in bluebird bio in Q4 2017 and held it in 3 quarters.
  • Zeke Capital Advisors's bluebird bio position peaked at $524K in Q1 2018.
  • 288 funds tracked by Wall St. Rank held bluebird bio as of Q3 2018.

Based on Zeke Capital Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.